Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries

Abstract

Introduction: In June 2022, experts from the oncology world gathered in Chicago, Illinois, for the American Society of Clinical Oncology (ASCO) 2022 annual meeting. In this article, we review the latest advancements presented at the conference regarding metastatic breast cancer [1]. Then, with experts in the field, we discuss the scientific findings from the studies presented and the practical implications of these data among breast cancer patients in low- and middle-income countries.